-
FDA’s View on Postmarket Drug Safety
FDA and Medscape series for healthcare professionals The interview features…
-
FDA Publicizes Strategic Plan to Clear Bottleneck of Orphan Designation Requests
The FDA has about 200 orphan drug designation requests that…
-
FDA Aims to Increase Rx Drug Competition & Reprioritize Generic Reviews
In its effort to increase competition in the prescription drugs…
-
FDA Issues Q&A Draft Guidance: Use of Electronic Records and Electronic Signatures in Clinical Investigations
On June 20, 2017, FDA issued the document Use of…
Latest Posts
Categories
- Best Practices
- Change Management
- Clinical
- Clinical Trials
- Collaboration
- Communication
- Complexity
- Governance
- International Clinical Trials Day
- Leadership
- Marketing
- Medical Education
- MSL
- Patient-centered
- Pharma News
- PMOs
- Portfolio Management
- Program Management
- Project Management
- Project Management Salaries
- Project/Program/Portfolio Management
- Recruiting
- Salaries
- Uncategorized
Tags
3SixtyPharma Alzheimer's Anti-IgE anti-inflammatory anti-TNF anti-TNF-? B-cell Biosimilar clinical clinical research CNS Communication CT-P13 DEMENTIA FDA gastrointestinal genome GI Inflammation Inflectra infliximab interchangeability investigational JAK inhibitor KTE-C19 Lymphoma oncology patients Pharma Portfolio Management Program Management Project Management rare disease remote Remsima rheumatoid arthritis spondyloarthritis switching Theravance Biopharma virtual w webinar White House White House Office of Management and Budget White House OMB